Objectives

After participating in this educational activity, attendees should be able to:
1|Describe autonomic and cardiac features unique to Trisomy 21.
2|Discuss why sevoflurane remains choice of induction agent in pediatric population.
3|Review characteristics of bradycardia on induction with sevoflurane in children in Down Syndrome.
4|Discuss proposed mechanisms for this complication.
5|Examine evidence linking sevoflurane to bradycardia in Down Syndrome.
6|Review management and prevention.

Presenter(s): 
Nishkruti Munshi, M.D.
Anesthesiologist
Department of Anesthesiology
Assistant Professor of Anesthesiology
UMass Chan Medical School - Baystate Medical Center

NameRoleFinancial Relationship DisclosuresDiscussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?
Nishkruti Munshi, M.D.Speaker/AuthorNo relevant relationships with ineligible companies to discloseNot Applicable
Session date: 
02/05/2026 - 7:00am to 8:00am EST
Location: 
Baystate Medical Center
759 Chestnut Street
Chicopee Agawam Conference Room
Springfield, MA 01199
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 IPCE Credit Hour(s)
Please login or register to take this course.